- Home
- PHGE vs MKZR Comparison
PHGE vs MKZR Comparison
Compare PHGE & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- MKZR
- Stock Information
- Founded
- PHGE 2015
- MKZR 2012
- Country
- PHGE Israel
- MKZR United States
- Employees
- PHGE N/A
- MKZR N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- MKZR
- Sector
- PHGE Health Care
- MKZR
- Exchange
- PHGE Nasdaq
- MKZR Nasdaq
- Market Cap
- PHGE 11.0M
- MKZR 11.4M
- IPO Year
- PHGE N/A
- MKZR N/A
- Fundamental
- Price
- PHGE $0.49
- MKZR $0.70
- Analyst Decision
- PHGE Strong Buy
- MKZR
- Analyst Count
- PHGE 1
- MKZR 0
- Target Price
- PHGE $15.00
- MKZR N/A
- AVG Volume (30 Days)
- PHGE 278.8K
- MKZR 66.3K
- Earning Date
- PHGE 08-13-2025
- MKZR 08-11-2025
- Dividend Yield
- PHGE N/A
- MKZR 55.34%
- EPS Growth
- PHGE N/A
- MKZR N/A
- EPS
- PHGE N/A
- MKZR N/A
- Revenue
- PHGE N/A
- MKZR $23,037,348.00
- Revenue This Year
- PHGE N/A
- MKZR N/A
- Revenue Next Year
- PHGE N/A
- MKZR N/A
- P/E Ratio
- PHGE N/A
- MKZR N/A
- Revenue Growth
- PHGE N/A
- MKZR 52.64
- 52 Week Low
- PHGE $0.34
- MKZR $0.63
- 52 Week High
- PHGE $3.86
- MKZR $5.50
- Technical
- Relative Strength Index (RSI)
- PHGE 51.35
- MKZR N/A
- Support Level
- PHGE $0.34
- MKZR N/A
- Resistance Level
- PHGE $0.51
- MKZR N/A
- Average True Range (ATR)
- PHGE 0.05
- MKZR 0.00
- MACD
- PHGE 0.01
- MKZR 0.00
- Stochastic Oscillator
- PHGE 77.53
- MKZR 0.00
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.